Barrington Research Maintains Outperform on OPKO Health, Maintains $2.25 Price Target
Portfolio Pulse from Benzinga Newsdesk
Barrington Research has reiterated its 'Outperform' rating for OPKO Health, maintaining a price target of $2.25. Analyst Michael Petusky continues to see potential in OPKO Health's stock.
September 20, 2024 | 3:28 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barrington Research has reiterated its 'Outperform' rating for OPKO Health, maintaining a price target of $2.25. Analyst Michael Petusky continues to see potential in OPKO Health's stock.
The reaffirmation of an 'Outperform' rating and a maintained price target by Barrington Research suggests continued confidence in OPKO Health's performance. This positive analyst sentiment is likely to have a favorable impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100